John Climacus

(redirected from John Climax)

John Climacus

 

Died between 650 and 680. Byzantine religious writer. Abbot of a monastery on Mount Sinai. His Heavenly Ladder is an ascetic and didactic treatise on the steps toward self-perfection and the moral pitfalls which a monk must be aware of. It reveals a rich experience of psychological introspection and abounds with narrative material. It was translated into many languages (including Latin and Arabic) and was read widely in the Middle Ages in Greece, Palestine, Syria, Georgia, Serbia, Bulgaria, and Rus’, where it influenced morality, literature, folklore, and iconography in the fine arts.

WORKS

Scala paradisi. Paris, 1864. (Patrologiae cursus completus: Seria graeca, vol. 88. Edited by J.-P. Migne.)
In Russian translation:
Lestvitsa, vozvodiashchaia k nebesam. Moscow, 1908.

REFERENCE

Bogdanović, D. lovan LestviĀnik. Belgrade, 1968.

S. S. AVERINTSEV

References in periodicals archive ?
Founders Ronan Lambe and John Climax are to sell one million and 500,000 shares, respectively, and the rest of the sale will comprise of new shares.
JAH223) JOHN CLIMAX, CEO of ICON CLINICAL RESEARCH PLC (ICLR), describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward.
John Climax will retire as Chairman of ICON Plc as of 31st December 2009, but will remain a board member.
John Climax, Chairman and CEO of DS will present at 10am (EDT) in the Sheraton New York Hotel, 811 Seventh Avenue, New York.
John Climax commented "I am very pleased with ICON's performance for the first nine months of 2009.
John Climax, Executive Chairman of ICON plc will preside over the closing bell to celebrate ICON's 8 year listing anniversary on the NASDAQ.
John Climax, PhD (SAB Chairman) is a founder and the current Executive Chairman of ICON Clinical Research plc, and a non-executive director of Amarin Corporation plc.
John Climax, " Revenues and operating profits for the first nine months of 2008, at $645 million and $73 million respectively, already exceed those achieved in all of 2007.
We are delighted to welcome Professor Dermot Kelleher to the Board of ICON", commented Chairman Dr John Climax.